Tumour cell inhibition of macrophage cytokine activity.
Macrophages elaborate both effector and regulatory immune functions. It was hypothesised that tumours can exert a local alteration of macrophage function. Murine peritoneal macrophage-derived cytokines were assayed in the presence and absence of cells, cytosol fractions or conditioned media (TCCM) from established murine tumour lines. Interleukin-1 beta, interleukin-6 and tumour necrosis factor-alpha activities were significantly inhibited by tumour cells or their products, as were the corresponding recombinant human cytokines. Intracellular protein kinase C activation was also measured and was significantly inhibited by murine TCCM, thus suggesting one possible site of inhibitor action. Data analyses indicate that the inhibitory factor(s) is probably not an already well-characterised macrophage inhibitor.
Hannigan
B M
BM
Department of Biological and Biomedical Sciences, University of Ulster, Coleraine, UK.
McNally
O R
OR
Kirrane
O
O
Eason
S J
SJ
D000818:Animals; D005260:Female; D007375:Interleukin-1 / Q000037:antagonists & inhibitors*; D008262:Macrophage Activation; D008264:Macrophages / Q000201:enzymology / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D011493:Protein Kinase C / Q000378:metabolism; D014407:Tumor Cells, Cultured / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D000093242:Interleukin-6 Inhibitors
D007375:Interleukin-1; D011493:Protein Kinase C; D014409:Tumor Necrosis Factor-alpha; D000093242:Interleukin-6 Inhibitors